Drug class

Precocious Puberty Agents

Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin. Read more about Precocious Puberty Agents

32 drugs in this class 15 manufacturers

Advertisement

Drugs in Precocious Puberty Agents

Showing 19–27 of 32 drugs

LEUPROLIDE ACETATE

LHRH(GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS · ADVANCED PROSTATIC CARCINOMA ·+1
PHARMACEU ASSOC

LEUPROLIDE ACETATE

LHRH(GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS · ADVANCED PROSTATIC CARCINOMA ·+1
EUGIA US LLC

LEUPROLIDE ACETATE

LHRH(GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS · ADVANCED PROSTATIC CARCINOMA ·+1
MEITHEAL PHARMA
Filter & compare in the drug finder → Opens the drug finder with Precocious Puberty Agents preselected. Add indication or manufacturer filters there.

About Precocious Puberty Agents.

Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin.

These agents work by continuously stimulating pituitary GnRH receptors, which paradoxically leads to receptor desensitization and down-regulation, thereby suppressing luteinizing hormone, follicle-stimulating hormone, and downstream gonadal sex steroids to prepubertal levels.

They are indicated for the management of central precocious puberty, where they arrest accelerated somatic development and prevent premature epiphyseal plate fusion to preserve adult stature.

In peripheral precocious puberty, adjunctive therapies such as aromatase inhibitors or androgen receptor blockers may be utilized depending on the underlying endocrine etiology.